A novel relay method for determining low-clearance values.

Abstract

A novel relay method has been developed using cryopreserved human hepatocytes to measure intrinsic clearance of low-clearance compounds. The relay method involved transferring the supernatant from hepatocyte incubations to freshly thawed hepatocytes at the end of the 4-h incubation to prolong the exposure time to active enzymes in hepatocytes. An accumulative incubation time of 20 h or longer in hepatoctyes can be achieved using the method. The relay method was validated using seven commercial drugs (diazepam, disopyramide, theophylline, timolol, tolbutamide, S-warfarin, and zolmitriptan) that were metabolized by various cytochrome P450s with low human in vivo intrinsic clearance at approximately 2 to 15 ml · min⁻¹ · kg⁻¹. The results showed that the relay method produced excellent predictions of human in vivo clearance. The difference between in vitro and in vivo intrinsic clearance was within 2-fold for most compounds, which is similar to the standard prediction accuracy for moderate to high clearance compounds using hepatocytes. The relay method is a straightforward, relatively low cost, and easy-to-use new tool to address the challenges of low clearance in drug discovery and development.

DOI: 10.1124/dmd.112.046425

6 Figures and Tables

050100201220132014201520162017
Citations per Year

225 Citations

Semantic Scholar estimates that this publication has 225 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Di2012ANR, title={A novel relay method for determining low-clearance values.}, author={Li Di and Patrick E. Trapa and Ronald Scott Obach and Karen A Atkinson and Yi-an Bi and Angela C. Wolford and Beijing Tan and Thomas S. McDonald and Yurong Lai and Larry M. Tremaine}, journal={Drug metabolism and disposition: the biological fate of chemicals}, year={2012}, volume={40 9}, pages={1860-5} }